Denali Therapeutics (DNLI) Return on Sales (2018 - 2026)
Denali Therapeutics (DNLI) posted quarterly Return on Sales of 3.36% for Q2 2024, down 336.0% year-over-year from 1.42% in Q3 2023, and down 70705.94% quarter-over-quarter from 0.0% in Q1 2024.
Denali Therapeutics (DNLI) Return on Sales (2018 - 2026) Analysis & Trends
Denali Therapeutics (DNLI) has reported Return on Sales for 7 consecutive years, with 3.36% the latest figure, recorded in Q2 2024.
- In Q2 2024, Return on Sales fell 336.0% year-over-year to 3.36%; the TTM figure through Jun 2024 stood at 3.36% (down 335.0% YoY), while the FY2023 annual figure was 0.0%, up 3.0% from the prior year.
- Return on Sales slipped to 3.36% in Q2 2024 per DNLI's latest filing, from 0.0% in the prior quarter.
- Across five years, Return on Sales topped out at 0.01% in Q4 2020 and bottomed at 10.92% in Q1 2020.
- Historically, Return on Sales has averaged 0.89% across 5 years, with a median of 0.05% in 2021.
- Annual changes were most pronounced in 2020 — Return on Sales plunged 1083 bps — and 2021, when it soared 1083 bps.
- Denali Therapeutics' Return on Sales stood at 0.01% in 2020, then sank by 300 bps to 0.02% in 2021, then plunged by 538 bps to 0.1% in 2022, then surged by 95 bps to 0.0% in 2023, then slumped by 74756 bps to 3.36% in 2024.
- Business Quant data shows DNLI's Return on Sales at 3.36% in Q2 2024, 0.0% in Q1 2024, and 0.0% in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 0.00% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 0.00% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 0.00% |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.00% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.00% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 0.00% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 0.00% |
| 10 | Denali Therapeutics | 3.90 Bn | 3.90 Bn | 3.51 Mn | -0.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -0.36% |
| Jun 30, 2024 | -3.36% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | -0.78% |
| Jun 30, 2023 | 0.01% |
| Mar 31, 2023 | -0.03% |
| Dec 31, 2022 | -0.10% |
| Sep 30, 2022 | -0.31% |
| Jun 30, 2022 | -0.01% |
| Mar 31, 2022 | -0.02% |
| Dec 31, 2021 | -0.02% |
| Sep 30, 2021 | -0.16% |
| Jun 30, 2021 | -0.04% |
| Mar 31, 2021 | -0.09% |
| Dec 31, 2020 | 0.01% |
| Sep 30, 2020 | -0.06% |
| Jun 30, 2020 | -0.10% |
| Mar 31, 2020 | -10.92% |
| Dec 31, 2019 | -0.36% |